Claire Tissot

Circulating free DNA concentration is an independent prognostic biomarker in lung cancer

Claire Tissot, Anne‐Claire Toffart, Stéphanie Villar et al. · European Respiratory Journal · 2015 · 150 citations · Full text

Clinical characteristics and outcome of patients with lung cancer harboring BRAF mutations

Claire Tissot, S. Couraud, Ronan Tanguy et al. · Lung Cancer · 2015 · 134 citations

Somatic Variant, Medicine, Braf Mutations +6

Brief Report: Severe Sotorasib-Related Hepatotoxicity and Non-Liver Adverse Events Associated With Sequential Anti–Programmed Cell Death (Ligand)1 and Sotorasib Therapy in KRASG12C-Mutant Lung Cancer

Ali Chour, Julie Denis, Céline Mascaux et al. · Journal of Thoracic Oncology · 2023 · 69 citations · Full text

Medicine, Liver Physiology, Apoptosis +11

Cross-platform comparison for the detection of RAS mutations in cfDNA (ddPCR Biorad detection assay, BEAMing assay, and NGS strategy)

Jessica Garcia, Julien Forestier, Eric Dusserre et al. · Oncotarget · 2018 · 54 citations · Full text

PD-L1 expression in pleomorphic, spindle cell and giant cell carcinoma of the lung is related to TTF-1, p40 expression and might indicate a worse prognosis

Violaine Yvorel, Arnaud Patoir, François Casteillo et al. · PLoS ONE · 2017 · 53 citations · Full text

Oncology, P40 Expression, Tumor Microenvironment +15